Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
Andrea Marcinnò, Erica Gallo, Fausto Roveta, Silvia Boschi, Alberto Grassini, Innocenzo Rainero, Elisa Rubino
Abstract
CSF concentration in patients (p < 0.001, r = 0.50). Lower resistin characterized AD patients in our study and AD, but not FTD, diagnosis risk was found to be inversely associated with resistin when controlling for confounders. We hypothesize that resistin-linked metabolic profile has to be reconsidered and further investigated in AD.
Topics & Concepts
ResistinAdipokineAdiponectinInternal medicineMedicineLeptinEndocrinologyNeurodegenerationDementiaCerebrospinal fluidCase-control studyFrontotemporal dementiaConfoundingDiseaseInsulin resistanceInsulinObesityAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and ObesityApelin-related biomedical research